1-109606352-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001377295.2(GNAT2):​c.546G>A​(p.Thr182Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.438 in 1,609,972 control chromosomes in the GnomAD database, including 162,031 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T182T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.37 ( 12575 hom., cov: 32)
Exomes 𝑓: 0.45 ( 149456 hom. )

Consequence

GNAT2
NM_001377295.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.20

Publications

35 publications found
Variant links:
Genes affected
GNAT2 (HGNC:4394): (G protein subunit alpha transducin 2) Transducin is a 3-subunit guanine nucleotide-binding protein (G protein) which stimulates the coupling of rhodopsin and cGMP-phoshodiesterase during visual impulses. The transducin alpha subunits in rods and cones are encoded by separate genes. This gene encodes the alpha subunit in cones. [provided by RefSeq, Jul 2008]
GNAT2 Gene-Disease associations (from GenCC):
  • achromatopsia 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • GNAT2-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • cone dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • achromatopsia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.25).
BP6
Variant 1-109606352-C-T is Benign according to our data. Variant chr1-109606352-C-T is described in ClinVar as Benign. ClinVar VariationId is 259744.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.2 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.617 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNAT2NM_001377295.2 linkc.546G>A p.Thr182Thr synonymous_variant Exon 6 of 9 ENST00000679935.1 NP_001364224.1
GNAT2NM_001379232.1 linkc.546G>A p.Thr182Thr synonymous_variant Exon 6 of 9 NP_001366161.1
GNAT2NM_005272.5 linkc.546G>A p.Thr182Thr synonymous_variant Exon 5 of 8 NP_005263.1 P19087Q5T697

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNAT2ENST00000679935.1 linkc.546G>A p.Thr182Thr synonymous_variant Exon 6 of 9 NM_001377295.2 ENSP00000505083.1 P19087
GNAT2ENST00000351050.8 linkc.546G>A p.Thr182Thr synonymous_variant Exon 5 of 8 1 ENSP00000251337.3 P19087

Frequencies

GnomAD3 genomes
AF:
0.368
AC:
55833
AN:
151818
Hom.:
12562
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.105
Gnomad AMI
AF:
0.225
Gnomad AMR
AF:
0.526
Gnomad ASJ
AF:
0.456
Gnomad EAS
AF:
0.635
Gnomad SAS
AF:
0.385
Gnomad FIN
AF:
0.497
Gnomad MID
AF:
0.468
Gnomad NFE
AF:
0.446
Gnomad OTH
AF:
0.400
GnomAD2 exomes
AF:
0.465
AC:
116935
AN:
251492
AF XY:
0.462
show subpopulations
Gnomad AFR exome
AF:
0.0971
Gnomad AMR exome
AF:
0.628
Gnomad ASJ exome
AF:
0.437
Gnomad EAS exome
AF:
0.641
Gnomad FIN exome
AF:
0.511
Gnomad NFE exome
AF:
0.450
Gnomad OTH exome
AF:
0.467
GnomAD4 exome
AF:
0.445
AC:
648962
AN:
1458036
Hom.:
149456
Cov.:
31
AF XY:
0.444
AC XY:
322256
AN XY:
725592
show subpopulations
African (AFR)
AF:
0.0917
AC:
3068
AN:
33466
American (AMR)
AF:
0.614
AC:
27474
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.438
AC:
11448
AN:
26108
East Asian (EAS)
AF:
0.664
AC:
26359
AN:
39686
South Asian (SAS)
AF:
0.402
AC:
34625
AN:
86178
European-Finnish (FIN)
AF:
0.509
AC:
27165
AN:
53416
Middle Eastern (MID)
AF:
0.498
AC:
2867
AN:
5758
European-Non Finnish (NFE)
AF:
0.442
AC:
489695
AN:
1108426
Other (OTH)
AF:
0.436
AC:
26261
AN:
60278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
18187
36374
54562
72749
90936
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14746
29492
44238
58984
73730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.368
AC:
55860
AN:
151936
Hom.:
12575
Cov.:
32
AF XY:
0.374
AC XY:
27785
AN XY:
74248
show subpopulations
African (AFR)
AF:
0.105
AC:
4360
AN:
41448
American (AMR)
AF:
0.526
AC:
8039
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.456
AC:
1581
AN:
3468
East Asian (EAS)
AF:
0.635
AC:
3275
AN:
5154
South Asian (SAS)
AF:
0.386
AC:
1856
AN:
4810
European-Finnish (FIN)
AF:
0.497
AC:
5232
AN:
10528
Middle Eastern (MID)
AF:
0.463
AC:
136
AN:
294
European-Non Finnish (NFE)
AF:
0.446
AC:
30326
AN:
67944
Other (OTH)
AF:
0.404
AC:
850
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1570
3141
4711
6282
7852
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.421
Hom.:
28676
Bravo
AF:
0.363
Asia WGS
AF:
0.481
AC:
1670
AN:
3478
EpiCase
AF:
0.448
EpiControl
AF:
0.462

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Achromatopsia 4 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.25
CADD
Benign
5.7
DANN
Benign
0.74
PhyloP100
-2.2
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1799875; hg19: chr1-110148974; COSMIC: COSV63554552; COSMIC: COSV63554552; API